Cargando…
Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders
In IVF/ICSI treatment, the FSH starting dose is often increased in predicted low responders from the belief that it improves the chance of having a baby by maximizing the number of retrieved oocytes. This intervention has been evaluated in several randomized controlled trials, and despite a slight i...
Autores principales: | Leijdekkers, Jori A, Torrance, Helen L, Schouten, Nienke E, van Tilborg, Theodora C, Oudshoorn, Simone C, Mol, Ben Willem J, Eijkemans, Marinus J C, Broekmans, Frank J M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7485616/ https://www.ncbi.nlm.nih.gov/pubmed/31838515 http://dx.doi.org/10.1093/humrep/dez184 |
Ejemplares similares
-
Reply: The low responder according to the POSEIDON criteria: is the prognosis really poor?
por: Leijdekkers, Jori A, et al.
Publicado: (2019) -
Endometrial scratching in women undergoing IVF/ICSI: an individual participant data meta-analysis
por: van Hoogenhuijze, Nienke E, et al.
Publicado: (2023) -
Cumulative live birth rates in low-prognosis women
por: Leijdekkers, Jori A, et al.
Publicado: (2019) -
Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Broekmans, Frank, et al.
Publicado: (2021) -
The OPTIMIST study: optimisation of cost effectiveness through individualised FSH stimulation dosages for IVF treatment. A randomised controlled trial
por: van Tilborg, Theodora C, et al.
Publicado: (2012)